Meta Biomed Co., Ltd. (KOSDAQ:059210)
3,680.00
+45.00 (1.24%)
At close: Nov 2, 2026
Meta Biomed Revenue
Meta Biomed had revenue of 26.99B KRW in the quarter ending June 30, 2026, with 5.95% growth. This brings the company's total for the last twelve months to 101.19B, up 1.82% year-over-year. In the year 2025, Meta Biomed had annual revenue of 102.95B with 9.48% growth. That makes Meta Biomed the 24,859th largest company in the world by revenue and 1,441st in South Korea.
Revenue (ttm)
101.19B
Revenue Growth
+1.82%
P/S Ratio
0.99
Revenue / Employee
305.70M
Employees
331
Market Cap
99.99B
Revenue by Segment
Fiscal year ended Dec 31, 2025 See the full Meta Biomed breakdown
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 102.95B | 8.92B | 9.48% |
| Dec 31, 2024 | 94.04B | 10.94B | 13.16% |
| Dec 31, 2023 | 83.10B | 14.16B | 20.54% |
| Dec 31, 2022 | 68.94B | 10.16B | 17.29% |
| Dec 31, 2021 | 58.78B | 13.78B | 30.63% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| DASAN Networks | 572.04B |
| Keeps Biopharma | 220.48B |
| TOPTEC | 173.29B |
| YTN Co.,Ltd. | 150.70B |
| OPTUS Pharmaceutical | 94.47B |
| Sung Woo Co.,Ltd | 89.28B |
| WOORIM POWER TRAIN SOLUTION | 55.95B |
| Dawon Nexview | 29.42B |